SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Seattle Genetics (SGEN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (23)5/16/2003 1:17:50 PM
From: Mike McFarland  Read Replies (1) of 161
 
SGEN is up about 50% over the past five sessions.

May 13, 2003-- Seattle Genetics, Inc. (Nasdaq:SGEN)
announced today that it has entered into a definitive
purchase agreement for the sale of $40 million of
Series A convertible preferred stock and warrants
to purchase common stock.

corporate-ir.net
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News